Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28204025 | 0.94 | TSHR (0.39) | TSHRSMN1; SMN2 | |
| SCHEMBL514688 | 0.84 | — | — | |
| SCHEMBL1390067 | 0.83 | TSHR (0.44) | TSHRSMN1; SMN2 | |
| SCHEMBL9883879 | 0.83 | TSHR (0.56) | TSHRSMN1; SMN2 | |
| SCHEMBL28655206 | 0.83 | TSHR (0.52) | TSHRSMN1; SMN2 | |
| 2-Methylpentanal SCHEMBL1939674 | 0.82 | — | — | |
| 2-Methylpentanal SCHEMBL3235073 | 0.82 | — | — | |
| 2-Methylpentanal SCHEMBL7749332 | 0.82 | TSHR (0.40) | TSHRSMN1; SMN2 | |
| 2-Methylpentanal SCHEMBL43746 | 0.82 | — | — | |
| 2-Methylpentanal SCHEMBL7111525 | 0.81 | TSHR (0.54) | TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4426542-A | HYDROFORMYLATION, ALDOL CONDENSATION, HYDROGENATION | MONSANTO COMPANY (US) | 1984-01-17 | — | — | US | claimed |
| CN-107429059-A | ENERGY-SENSITIVE RESIN COMPOSITION | 东京应化工业株式会社 | 2017-12-01 | — | — | CN | disclosed |
| US-7906688-B2 | Calixarene bisphosphite ligand for use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES INC. | 2011-03-15 | — | — | US | disclosed |
| US-20100044628-A1 | CALIXARENE BISPHOSPHITE LIGAND FOR USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES LLC | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100044628-A1 | CALIXARENE BISPHOSPHITE LIGAND FOR USE IN HYDROFORMYLATION PROCESSES | CALU, PFKFB3, PFKFB4 | TSHR 3322/4885SMN1; SMN2 3591/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.